Neogen Chemicals Ltd.

As of June 30, 2026, Neogen Chemicals Ltd. carries a market capitalization of 55.48B, placing it among publicly traded companies globally. Its enterprise value stands at 55.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Neogen Chemicals Ltd.'s next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Neogen Chemicals Ltd. has 27.38M shares outstanding.

As of June 30, 2026, Neogen Chemicals Ltd. trades at a trailing price-to-earnings ratio of 151.34.

As of June 30, 2026, Neogen Chemicals Ltd. trades at an EV/EBITDA multiple of 35.85 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.99 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 44.45 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 55.48B versus a market cap of 55.48B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 9.47M in revenue per employee across its workforce of 977.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Neogen Chemicals Ltd. recorded 144.80M in income tax expense. That works out to an effective tax rate of 28.94, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 500.40M, leaving 355.60M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Neogen Chemicals Ltd.'s stock has gained approximately 48.09% over the past 52 weeks. The 50-day moving average sits at 2,318.45, while the 200-day moving average is 1,785.45.

Over the twelve months ended June 30, 2026, Neogen Chemicals Ltd. generated 9.26B in revenue and converted that into 355.60M in net income, yielding earnings per share of 13.39. EBITDA reached 1.55B, while operating income came in at 1.25B.

Over the twelve months ended June 30, 2026, Neogen Chemicals Ltd. posted a gross margin of 46.22, reflecting its pricing power and cost economics. The operating margin of 13.48 and net profit margin of 3.84 provide insight into operational efficiency.